SAB Biotherapeutics, Inc.
SABS
$3.70
-$0.05-1.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 102.63M | 107.39M | 96.59M | 110.88M | 5.71M |
| Total Receivables | 1.84M | 1.56M | 946.80K | 560.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.46M | 3.84M | 3.51M | 1.84M | 3.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 107.94M | 112.78M | 101.05M | 113.28M | 9.31M |
|
|
|||||
| Total Current Assets | 107.94M | 112.78M | 101.05M | 113.28M | 9.31M |
| Net Property, Plant & Equipment | 19.58M | 20.17M | 19.41M | 19.44M | 20.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.34M | 5.28M | 5.46M | 124.10K | 417.50K |
| Total Assets | 238.21M | 248.47M | 172.81M | 183.45M | 30.13M |
|
|
|||||
| Total Accounts Payable | 3.86M | 3.55M | 3.15M | 2.96M | 2.62M |
| Total Accrued Expenses | 7.21M | 5.39M | 6.58M | 6.85M | 7.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 641.00K | 920.70K | 951.40K | 988.30K | 963.20K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.71M | 9.85M | 10.68M | 10.79M | 10.68M |
|
|
|||||
| Total Current Liabilities | 11.71M | 9.85M | 10.68M | 10.79M | 10.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.49M | 5.25M | 5.00M | 5.20M | 5.46M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.23M | 6.12M | 5.64M | 2.38M | 1.98M |
| Total Liabilities | 23.43M | 21.22M | 21.32M | 18.37M | 18.11M |
|
|
|||||
| Common Stock & APIC | 373.49M | 362.76M | 267.72M | 264.56M | 157.03M |
| Retained Earnings | -152.26M | -129.76M | -110.90M | -94.03M | -139.48M |
| Treasury Stock & Other | -6.45M | -5.74M | -5.33M | -5.45M | -5.54M |
| Total Common Equity | 214.79M | 227.25M | 151.49M | 165.07M | 12.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 100.00 | 100.00 | 100.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 100.00 | 100.00 | 100.00 | 0.00 |
|
|
|||||
| Total Common Equity | 214.79M | 227.25M | 151.49M | 165.07M | 12.02M |
| Total Preferred Equity | -- | 100.00 | 100.00 | 100.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 214.79M | 227.25M | 151.49M | 165.07M | 12.02M |
|
|
|||||